vs
CORVEL CORP（CRVL）与天瑞祥控股有限公司（TIRX）财务数据对比。点击上方公司名可切换其他公司
CORVEL CORP的季度营收约是天瑞祥控股有限公司的117.1倍（$235.6M vs $2.0M）。CORVEL CORP净利率更高（10.3% vs -12.3%，领先22.6%）。CORVEL CORP同比增速更快（3.4% vs -35.8%）。CORVEL CORP自由现金流更多（$35.2M vs $263.1K）
Corvel Corp是一家总部位于美国的综合解决方案供应商，核心业务涵盖工伤赔偿、医疗管理与风险缓释，服务客户包括保险公司、自保雇主及公共部门机构，可帮助客户控制医疗成本、提升护理效果、优化行政运营流程。
天瑞祥控股有限公司是总部位于中国的保险中介服务提供商，代理销售多家合作保险公司的财险、意外险、寿险等多元保险产品，主要服务中国大陆各区域的个人及企业客户。
CRVL vs TIRX — 直观对比
营收规模更大
CRVL
是对方的117.1倍
$2.0M
营收增速更快
CRVL
高出39.1%
-35.8%
净利率更高
CRVL
高出22.6%
-12.3%
自由现金流更多
CRVL
多$34.9M
$263.1K
损益表 — Q4 2025 vs Q2 2025
| 指标 | | |
|---|---|---|
| 营收 | $235.6M | $2.0M |
| 净利润 | $24.2M | $-248.3K |
| 毛利率 | 23.3% | 85.6% |
| 营业利润率 | 13.7% | -6.7% |
| 净利率 | 10.3% | -12.3% |
| 营收同比 | 3.4% | -35.8% |
| 净利润同比 | 1.7% | -159.3% |
| 每股收益（稀释后） | $0.47 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRVLTIRX
| Q4 25 | $235.6M | — | ||
| Q3 25 | $239.6M | — | ||
| Q2 25 | $234.7M | $2.0M | ||
| Q1 25 | $231.5M | — | ||
| Q4 24 | $228.0M | — | ||
| Q3 24 | $224.4M | — | ||
| Q2 24 | $211.7M | $3.1M | ||
| Q1 24 | $207.2M | — |
净利润CRVLTIRX
| Q4 25 | $24.2M | — | ||
| Q3 25 | $27.9M | — | ||
| Q2 25 | $27.2M | $-248.3K | ||
| Q1 25 | $26.4M | — | ||
| Q4 24 | $23.8M | — | ||
| Q3 24 | $23.4M | — | ||
| Q2 24 | $21.6M | $418.9K | ||
| Q1 24 | $19.5M | — |
毛利率CRVLTIRX
| Q4 25 | 23.3% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 24.2% | 85.6% | ||
| Q1 25 | 25.0% | — | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | 22.6% | — | ||
| Q2 24 | 22.7% | 89.7% | ||
| Q1 24 | 20.9% | — |
营业利润率CRVLTIRX
| Q4 25 | 13.7% | — | ||
| Q3 25 | 15.0% | — | ||
| Q2 25 | 15.0% | -6.7% | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 13.5% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | 13.2% | 18.6% | ||
| Q1 24 | 10.9% | — |
净利率CRVLTIRX
| Q4 25 | 10.3% | — | ||
| Q3 25 | 11.6% | — | ||
| Q2 25 | 11.6% | -12.3% | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 10.4% | — | ||
| Q2 24 | 10.2% | 13.4% | ||
| Q1 24 | 9.4% | — |
每股收益（稀释后）CRVLTIRX
| Q4 25 | $0.47 | — | ||
| Q3 25 | $0.54 | — | ||
| Q2 25 | $0.52 | $-0.02 | ||
| Q1 25 | $-1.23 | — | ||
| Q4 24 | $0.46 | — | ||
| Q3 24 | $1.35 | — | ||
| Q2 24 | $1.25 | $0.01 | ||
| Q1 24 | $1.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $230.0M | $28.0M |
| 总债务越低越好 | — | $3.5M |
| 股东权益账面价值 | $375.7M | $-16.1M |
| 总资产 | $644.8M | $6.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRVLTIRX
| Q4 25 | $230.0M | — | ||
| Q3 25 | $207.5M | — | ||
| Q2 25 | $202.0M | $28.0M | ||
| Q1 25 | $170.6M | — | ||
| Q4 24 | $162.9M | — | ||
| Q3 24 | $138.3M | — | ||
| Q2 24 | $131.9M | $27.5M | ||
| Q1 24 | $105.6M | — |
总债务CRVLTIRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CRVLTIRX
| Q4 25 | $375.7M | — | ||
| Q3 25 | $362.8M | — | ||
| Q2 25 | $342.5M | $-16.1M | ||
| Q1 25 | $322.0M | — | ||
| Q4 24 | $300.9M | — | ||
| Q3 24 | $282.8M | — | ||
| Q2 24 | $263.9M | $32.3M | ||
| Q1 24 | $247.6M | — |
总资产CRVLTIRX
| Q4 25 | $644.8M | — | ||
| Q3 25 | $611.7M | — | ||
| Q2 25 | $597.4M | $6.0M | ||
| Q1 25 | $546.0M | — | ||
| Q4 24 | $538.8M | — | ||
| Q3 24 | $518.6M | — | ||
| Q2 24 | $486.2M | $38.0M | ||
| Q1 24 | $454.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.1M | $263.7K |
| 自由现金流经营现金流 - 资本支出 | $35.2M | $263.1K |
| 自由现金流率自由现金流/营收 | 14.9% | 13.1% |
| 资本支出强度资本支出/营收 | 4.7% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.91× | — |
| 过去12个月自由现金流最近4个季度 | $104.3M | — |
8季度趋势，按日历期对齐
经营现金流CRVLTIRX
| Q4 25 | $46.1M | — | ||
| Q3 25 | $25.0M | — | ||
| Q2 25 | $55.0M | $263.7K | ||
| Q1 25 | $22.9M | — | ||
| Q4 24 | $41.6M | — | ||
| Q3 24 | $22.3M | — | ||
| Q2 24 | $40.4M | $-646.8K | ||
| Q1 24 | $15.2M | — |
自由现金流CRVLTIRX
| Q4 25 | $35.2M | — | ||
| Q3 25 | $15.3M | — | ||
| Q2 25 | $39.5M | $263.1K | ||
| Q1 25 | $14.3M | — | ||
| Q4 24 | $32.1M | — | ||
| Q3 24 | $12.4M | — | ||
| Q2 24 | $32.8M | — | ||
| Q1 24 | $5.2M | — |
自由现金流率CRVLTIRX
| Q4 25 | 14.9% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 16.8% | 13.1% | ||
| Q1 25 | 6.2% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 15.5% | — | ||
| Q1 24 | 2.5% | — |
资本支出强度CRVLTIRX
| Q4 25 | 4.7% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 6.6% | 0.0% | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 4.8% | — |
现金转化率CRVLTIRX
| Q4 25 | 1.91× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 1.75× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.87× | -1.54× | ||
| Q1 24 | 0.78× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRVL
| Patient Management Services | $146.1M | 62% |
| Network Solutions Services | $89.6M | 38% |
TIRX
暂无分部数据
